Nebraska pausing use of Johnson & Johnson vaccine
State health officials say Nebraska is pausing administration of the Johnson & Johnson/Janssen COVID-19 vaccine, following CDC and FDA recommendations.
LINCOLN, Neb. (KLKN) — State health officials say Nebraska is pausing administration of the Johnson & Johnson/Janssen COVID-19 vaccine, following CDC and FDA recommendations.
On Thursday, April 8th, DHHS, the Douglas County Health Department, and Nebraska Medicine consulted with CDC and FDA about a rare and severe type of blood clot diagnosed in a Nebraska resident.
On Tuesday, April 13th, CDC and FDA released a joint statement recommending a pause on Johnson & Johnson/Janssen vaccinations nationwide while more investigation is completed.
Six instances of this severe clotting event have been identified among approximately 6.8 million who have received the J&J/Janssen vaccine across the US.
DHHS says the pause is a transparent and deliberate decision to allow time for a thorough review and investigation.
DHHS is communicating the pause to local health departments, healthcare providers, and pharmacies across the state.
At this time there are no recommendations to pause the use of the other two vaccines, Pfizer and Moderna.
DHHS says these two vaccines should be provided in place of the Johnson and Johnson /Janssen vaccine until further notice.